[
  {
    "ts": null,
    "headline": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
    "summary": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=695b4bb6fa85acb9280c5ada56178f45856f38345ded6549de084958c2c069dc",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769186760,
      "headline": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
      "id": 138239671,
      "image": "",
      "related": "BDX",
      "source": "MarketWatch",
      "summary": "Becton Dickinson & Co. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=695b4bb6fa85acb9280c5ada56178f45856f38345ded6549de084958c2c069dc"
    }
  },
  {
    "ts": null,
    "headline": "BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI roadmap while strengthening its leadership in flow cytometry and life sciences research. The new release introduces BD Horizon™ Panel Maker, an AI-powered tool for automated panel design – one of the most critical steps across immunology and cancer research experiments designed to help ensure the quality",
    "url": "https://finnhub.io/api/news?id=1afb77cc3b9d59c150c863ee9e26d3ed2bd46cd1d6f95400ced90eca8f35b19f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1769169000,
      "headline": "BD Helps Scientists Advance Immunology and Cancer Research with AI-Powered Insights and Automation",
      "id": 138223527,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global commercial release of BD® Research Cloud 7.0, furthering the company's AI roadmap while strengthening its leadership in flow cytometry and life sciences research. The new release introduces BD Horizon™ Panel Maker, an AI-powered tool for automated panel design – one of the most critical steps across immunology and cancer research experiments designed to help ensure the quality",
      "url": "https://finnhub.io/api/news?id=1afb77cc3b9d59c150c863ee9e26d3ed2bd46cd1d6f95400ced90eca8f35b19f"
    }
  }
]